GROM (GROM) Stock Price & Analysis
GROM (GROM) rose 0.00% to USD 0 as of June 10, 2026 at 03:42 UTC, according to Nexqual real-time market data.
GROM last closed at USD 0; the session ranged USD 0–0 on volume of 350 shares. Market capitalization is $902, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 03:42 UTC.
Key Statistics (as of June 10, 2026 at 03:42 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 350 shares |
| Market Cap | $902 |
| Exchange | PNK |
Technical Analysis (GROM)
Nexqual's technical model rates GROM "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 03:42 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 50 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (GROM)
Wall Street analysts rate GROM "None", per Nexqual as of June 10, 2026 at 03:42 UTC.
| Consensus Rating | None |
|---|
Earnings (GROM)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2023-09-30 | USD -3 vs est -5.4 ▲ beat |
| 2023-06-30 | USD -5.4 vs est -5.6 ▲ beat |
| 2023-03-31 | USD -8.6 vs est -9.8 ▲ beat |
| 2022-12-31 | USD -298.26 vs est -42 ▼ miss |
Source: Nexqual, June 10, 2026 at 03:42 UTC.
Financials & Fundamentals (GROM)
| Total Revenue | $3.72M |
|---|---|
| Revenue Growth (YoY) | -27.10% |
| Gross Margin | +29.30% |
| Operating Margin | -201.44% |
| Profit Margin | +0.00% |
| ROE | -88.67% |
| Debt / Equity | 7.62 |
| Current Ratio | 0.6 |
| Total Cash | $452,454 |
| Total Debt | $1.11M |
| Free Cash Flow | $-2.13M |
Source: Nexqual, June 10, 2026 at 03:42 UTC.
Financial Health Score (GROM)
Nexqual rates GROM's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:42 UTC.
| Growth | Critical — Revenue -14% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $452K cash vs $1M debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Critical — ROE -89%, ROA -24.4% |
Ownership (GROM)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 9.02M |
| Float | 8.85M |
| Short % of Float | +1.31% |
Source: Nexqual, June 10, 2026 at 03:42 UTC.
Leadership (GROM)
GROM is led by Darren M. Marks (age 57), President, CEO & Chairman, per Nexqual as of June 10, 2026 at 03:42 UTC.
| President, CEO & Chairman | Darren M. Marks (age 57) |
|---|---|
| CFO, Secretary & Treasurer | Jason A. Williams (age 51) |
| President of Grom Social & Executive VP | Paul Ward |
| President & Chief Content Officer of Curiosity Ink Media and President of Top Draw Animation | Russell Hicks |
Major Backers & Investors (GROM)
Notable institutional backers of GROM include Xtx Topco Ltd, according to Nexqual as of June 10, 2026 at 03:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Xtx Topco Ltd | 0.18% |
Source: Nexqual, June 10, 2026 at 03:42 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DBGI | Digital Brands Group, Inc. | USD 1.07 | ▲ 24.42% |
| DATS | DatChat, Inc. | USD 2.66 | ▲ 16.96% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.25 | ▲ 0% |
| KAVL | Kaival Brands Innovations Group | USD 0.05 | ▼ 17% |
| PTPI | Petros Pharmaceuticals, Inc. | USD 0.01 | ▲ 8.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:42 UTC. This page is informational and not investment advice.